Alto Neuroscience (ANRO) Share-based Compensation (2023 - 2026)

Alto Neuroscience has reported Share-based Compensation for 4 years, with the latest figure at $190000.0 in Q1 2026.

• Quarterly Share-based Compensation fell 90.35% year-over-year to $190000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.8 million (down 135.31% YoY) and the FY2024 annual result came in at $5.2 million, up 81.46% from the prior year.
• Share-based Compensation rose to $190000.0 in Q1 2026 per ANRO's latest filing, from -$6.2 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $2.2 million in Q3 2025 and troughed at -$6.2 million in Q4 2025.
• A 4-year average of $693916.7 and a median of $1.2 million in 2023 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2024 and 2026: Share-based Compensation jumped 350.21% in 2024, then plunged 90.35% in 2026.
• Over 4 years, Share-based Compensation stood at $606000.0 in 2023, then jumped by 94.55% to $1.2 million in 2024, then slumped by 622.65% to -$6.2 million in 2025, then jumped by 103.08% to $190000.0 in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $190000.0, -$6.2 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.